doi.org/10.1111/bph.13317, hdl.handle.net/1765/85204
British Journal of Pharmacology
Department of Medical Oncology

Huisman, S.A, de Bruijn, P.J, Ghobadi Moghadam-Helmantel, I.M, IJzermans, J.N.M, Wiemer, E.A.C, Mathijssen, A.H.J, & de Bruin, R.W.F. (2016). Fasting protects against the side effects of irinotecan treatment but does not affect anti-tumour activity in mice. British Journal of Pharmacology, 173(5), 804–814. doi:10.1111/bph.13317